GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apex Biotechnology Corp (TPE:1733) » Definitions » Market Cap

Apex Biotechnology (TPE:1733) Market Cap : NT$3,343 Mil (As of Jun. 02, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Apex Biotechnology Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Apex Biotechnology's share price for the quarter that ended in Mar. 2024 was NT$33.85. Apex Biotechnology's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 100 Mil. Therefore, Apex Biotechnology's market cap for the quarter that ended in Mar. 2024 was NT$3,383 Mil.

Apex Biotechnology's quarterly market cap increased from Sep. 2023 (NT$2,689 Mil) to Dec. 2023 (NT$4,028 Mil) but then declined from Dec. 2023 (NT$4,028 Mil) to Mar. 2024 (NT$3,383 Mil).

Apex Biotechnology's annual market cap declined from Dec. 2021 (NT$2,599 Mil) to Dec. 2022 (NT$2,554 Mil) but then increased from Dec. 2022 (NT$2,554 Mil) to Dec. 2023 (NT$4,028 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Apex Biotechnology's Enterprise Value for Today is NT$3,044 Mil.


Apex Biotechnology Market Cap Historical Data

The historical data trend for Apex Biotechnology's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Biotechnology Market Cap Chart

Apex Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,833.58 2,355.23 2,598.70 2,553.72 4,027.99

Apex Biotechnology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,578.71 2,843.58 2,688.66 4,027.99 3,383.31

Competitive Comparison of Apex Biotechnology's Market Cap

For the Biotechnology subindustry, Apex Biotechnology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apex Biotechnology's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apex Biotechnology's Market Cap distribution charts can be found below:

* The bar in red indicates where Apex Biotechnology's Market Cap falls into.



Apex Biotechnology Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Apex Biotechnology's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$40.3*99.95
=NT$4,028

Apex Biotechnology's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=NT$33.85*99.95
=NT$3,383

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Apex Biotechnology  (TPE:1733) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Apex Biotechnology Market Cap Related Terms

Thank you for viewing the detailed overview of Apex Biotechnology's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Apex Biotechnology (TPE:1733) Business Description

Traded in Other Exchanges
N/A
Address
No.7, Li-Hsin 5th Road, Hsinchu Science Park, Hsinchu, TWN, 30078
Apex Biotechnology Corp engages mainly in research, development, production, manufacturing and selling of biochemical testing instruments and its detection strips, and trade of products and components relevant to the core business. The company develops and markets biosensor-based blood glucose monitoring systems. The company manufactures non-invasive diagnostic technologies, IT-based telehealth care and molecular diagnostic and traditional Chinese medicine. Its product offerings include Eclipse plus multipurpose analyzer, Glucosure HT blood glucose monitoring system, HemoSmart GOLD hemoglobin screening system among others.

Apex Biotechnology (TPE:1733) Headlines

No Headlines